All Pharma News
Syros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial

Syros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial
BUSINESSWIRE
12 Aug 2024
Share Share
Syros Reports Q2 2024 Results And Provides Business Update

Syros Reports Q2 2024 Results And Provides Business Update
BUSINESSWIRE
31 Jul 2024
Share Share
Syros To Report Q2 2024 Results On July 31

Syros To Report Q2 2024 Results On July 31
BUSINESSWIRE
24 Jul 2024
Share Share
Syros To Host Webcast On MDS, Tamibarotene Opportunity In RARA Overexpression

Syros To Host Webcast On MDS, Tamibarotene Opportunity In RARA Overexpression
BUSINESSWIRE
13 Jun 2024
Share Share
Syros Reports Q1 2024 Results, Corporate Update

Syros Reports Q1 2024 Results, Corporate Update
BUSINESSWIRE
14 May 2024
Share Share
Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
BUSINESSWIRE
07 May 2024
Share Share
Syros to Participate in Upcoming Investor Conferences

Syros to Participate in Upcoming Investor Conferences
BUSINESSWIRE
07 May 2024
Share Share
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
02 Apr 2024
Share Share
Syros Reports Fourth Quarter and Full Year 2023 Financial Results

Syros Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
27 Mar 2024
Share Share
Syros to Participate in TD Cowen 44th Annual Health Care Conference

Syros to Participate in TD Cowen 44th Annual Health Care Conference
BUSINESSWIRE
27 Feb 2024
Share Share